Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 69

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 69
---
 and we may have to expend significant resources to mitigate the impact of such an event,
and to develop and implement protections to prevent future events of this nature from occurring.

If any such incidents were
to occur and cause interruptions in our operations, it could result in a disruption of our business and development programs. For example,
the loss of clinical trial data from completed or ongoing clinical trials for a product candidate could result in delays in our regulatory
approval efforts and significantly increase our costs to recover or reproduce the data, or may limit our ability to effectively execute
a product recall, if required in the future. To the extent that any disruption or cybersecurity incident were to result in the loss of
or damage to our data or applications, or inappropriate disclosure of personal, confidential or proprietary information, we could incur
liability and the further development of any product candidates could be delayed. Applicable data privacy and security obligations may
require us to notify relevant stakeholders, regulatory authorities, and other individuals of cybersecurity incidents, and take other remedial
measures. Such disclosures and measures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse
consequences. Any such event could also result in legal claims or proceedings, liability under laws that protect the privacy of personal
information and significant regulatory penalties, and damage to our reputation and a loss of confidence in us and our ability to conduct
clinical trials, which could delay the clinical development of our product candidates.

We may incur substantial costs in our efforts to comply with evolving global data protection laws and regulations, and any failure or perceived failure by us to comply with such laws and regulations may harm our business and operations.

We maintain a large quantity of sensitive information, including confidential business and personal information in connection with the conduct of our clinical trials and related to our employees, and we are subject to laws and regulations governing the privacy and security of such information. In the United States, there are numerous federal and state privacy and data security laws and regulations governing the collection, use, disclosure and protection of personal information, including federal and state health information privacy laws, federal and state security breach notification laws, and federal and state consumer protection laws. The legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues, including with respect to regulatory enforcement and private litigation, which may affect our business and is expected to increase our compliance costs and exposure to liability. In the United States, numerous federal and state laws and regulations could apply to our